U.S. Communications Stock News

Vera Therapeutics recently announced it had reached alignment with the U.S. FDA on an earlier Phase 3 ORIGIN eGFR analysis plan to support potential full approval of atacicept for adults with IgA nephropathy, with a PDUFA date set for July 7, 2026 and eGFR data expected in the third quarter of 2026. An interesting aspect of this update is the accelerated regulatory pathway, which could allow Vera to file a supplemental Biologics License Application in late 2026, tightening the overall...

Hilton Grand Vacations (HGV) has drawn investor attention after recent share price moves, with the stock showing double digit returns over the past month and past 3 months and a one year total return of 39.2%. See our latest analysis for Hilton Grand Vacations. The recent 2.1% one day and 9.7% 7 day share price returns, combined with a 39.2% one year total shareholder return, suggest momentum has been building as investors reassess Hilton Grand Vacations' growth prospects and risk profile. If...

NASA imaging contracts put Intuitive Machines (LUNR) in focus for lunar infrastructure investors Intuitive Machines (LUNR) has drawn fresh attention after being selected as prime contractor for NASA’s Lunar Reconnaissance Orbiter Camera and the ShadowCam instrument under two three year contracts totaling US$20.0 million. See our latest analysis for Intuitive Machines. Despite the 12.82% decline in the 1 day share price return to US$38.21, recent momentum has been strong, with a 49.14% 30 day...

Corning stock snapshot after recent performance shifts Corning (GLW) has drawn fresh attention after a mixed stretch in its share performance, with the stock down 2.5% over the past day and 8.9% over the past week, but up over the month. For investors tracking the longer view, Corning shows reported total returns of 257% over the past year, about 510% over three years, and roughly 372% over five years, set against revenue of US$16.3b and net income of US$1.8b. See our latest analysis for...

Brown-Forman (BF.B) has been drawing attention after a period of weaker share performance, with the stock down 2.2% over the past day and 10.6% over the past 3 months. See our latest analysis for Brown-Forman. That recent 2.2% one day share price decline fits into a weaker pattern, with the stock down 10.6% on a 3 month share price basis and the 1 year total shareholder return falling 21.7%. This suggests that momentum has been fading rather than building. If Brown-Forman’s recent performance...

Westinghouse Air Brake Technologies (WAB) has been drawing attention after recent share price moves, with the stock down about 2% on the day, 3% over the past month, and 2% over the past 3 months. See our latest analysis for Westinghouse Air Brake Technologies. Those recent pullbacks sit against a stronger backdrop, with the share price up 18.37% year to date and a 1 year total shareholder return of 27.53%, suggesting momentum has generally been positive despite short term weakness. If you...

Diamondback Energy (FANG) is back in focus after strong first quarter production results, upbeat commentary from media and fund investors, and analyst rating reiterations that highlighted its Permian Basin acreage and disciplined management. See our latest analysis for Diamondback Energy. At a share price of US$199.03, Diamondback’s 1 day share price return of 3.9% and 90 day share price return of 12.1% sit alongside a 1 year total shareholder return of 48.4%. This indicates momentum has been...

Recent performance snapshot Twist Bioscience (TWST) has drawn fresh attention in early June as investors reassess the stock after a strong year to date move. The share price last closed at $67.86. The company now carries a market value of about $4.16b, with reported annual revenue of $409.479 million and a net loss of $81.276 million. This is setting the stage for closer scrutiny of its growth profile and risks. See our latest analysis for Twist Bioscience. Beyond the latest move, Twist...

Investors may be wondering if Sherwin-Williams at around US$294.86 is a bargain or just fairly priced, especially after a choppy run for the stock. The share price is down about 4.6% over the past week, 7.3% over the past month, and 10.1% year to date, with a 16.3% decline over the last year, but a gain of 26.3% over three years and 9.8% over five years. These mixed returns have kept Sherwin-Williams on many watchlists, with investors weighing long term prospects against recent share price...

What recent performance signals for H&R Block (HRB) H&R Block (HRB) has drawn fresh attention after a strong month, with the stock up about 27% over that period and about 26% over the past 3 months, against weaker year-to-date and 1-year returns. See our latest analysis for H&R Block. The recent 30 day share price return of 26.62% and 90 day return of 25.62% sit against a weaker year to date share price return and a 1 year total shareholder return that declined 29.73%, while the 3 and 5 year...

In Q1 2026, Joby Aviation reported US$24.0 million in revenue, reaffirmed its 2026 revenue outlook of US$105.0–US$115.0 million, and highlighted continued FAA certification progress despite ongoing operating losses from investment spending. This combination of stronger-than-expected revenue, unchanged full-year guidance, and visible regulatory progress has renewed attention on how Joby’s early commercialization plans might unfold. Next, we’ll examine how Joby’s reaffirmed 2026 revenue...

EQT (NYSE:EQT) is being highlighted as a key natural gas supplier to power hungry data centers, linked to growing AI and digital infrastructure demand. The company is also connected to a major new €21b infrastructure fund, EQT Infrastructure VII, targeting AI focused digital assets such as data centers and power grids. These developments are emerging as fresh topics in recent news coverage, separate from routine earnings or valuation commentary. For you as an investor, this positions EQT at...

In May 2026, Alkermes plc reported that it had presented new clinical and real-world evidence on its psychiatry portfolio, LYBALVI and ARISTADA, alongside sleep-medicine research across major U.S. psychiatric and health economics conferences, including APA, ISPOR, and others. A particularly important angle is Alkermes’ focus on real-world outcomes such as adherence, relapse proxies, and acute care use, which can influence how clinicians and payers view the practical value of LYBALVI versus...

With no single headline event driving GeneDx Holdings (WGS) today, the stock’s recent moves invite a closer look at how its genetic testing business and financial profile are lining up for investors. See our latest analysis for GeneDx Holdings. Recent trading has been choppy, with a 7 day share price return of about 9.9% following a 30 day share price decline of roughly 20.5%. The year to date share price return is down around 60.7%, and the 3 year total shareholder return remains very large,...

Disc Medicine has launched a U.S. expanded access program for bitopertin in erythropoietic and X-linked protoporphyria and presented updated Phase 2 RALLY-MF data for DISC-0974 in myelofibrosis-related anemia, showing clinically meaningful improvements in hemoglobin, transfusion needs, and fatigue with a generally well-tolerated safety profile. Together, these updates underscore Disc Medicine’s push to advance multiple late-stage hematology candidates, with DISC-0974’s broad responses across...

Recent performance snapshot Starbucks (SBUX) stock has slipped about 2.7% over the past day and 6.4% over the past week, extending a decline of roughly 8.9% in the past month. See our latest analysis for Starbucks. The recent pullback fits into a mixed picture for Starbucks, with the share price up 14.93% year to date but a 5 year total shareholder return of 2.59% below break even. This suggests that momentum has cooled after earlier strength. If this shift in sentiment has you reassessing...

Wondering whether Abbott Laboratories at US$87.78 is starting to look interesting on valuation, or if the market still sees more downside risk than upside. The stock is up 0.4% over the last week but down 1.9% over the last 30 days, with year to date and 1 year returns declining 29.3% and 32.9% respectively, which puts recent moves in sharp contrast to longer term performance. These returns have kept Abbott Laboratories in focus alongside ongoing sector wide interest in healthcare companies,...

Why Affirm Holdings (AFRM) Is Back On Investor Radars Affirm Holdings (AFRM) has drawn fresh attention after a strong past 3 months for the stock, prompting investors to reassess how its buy now, pay later model fits into diversified financials exposure. See our latest analysis for Affirm Holdings. At a share price of $72.91, Affirm’s recent run includes a 52.44% 90 day share price return and a 37.83% 1 year total shareholder return. Year to date momentum has eased slightly, hinting at...

In recent days, SCIEX, a Danaher company, announced platform-wide upgrades to its accurate mass ZenoTOF line and unveiled the novus V55 next-generation triple quadrupole mass spectrometer, both coupled with new AI-enabled SCIEX OS 5.0 software to streamline complex omics and high-throughput laboratory workflows. By combining higher sensitivity instruments, broader front-end compatibility, and AI-supported workflow tools, these launches deepen Danaher’s presence in data-intensive life science...

Opendoor Technologies has recently begun testing an AI-native mortgage platform in Colorado, offering homebuyers rates roughly 100 basis points below prevailing market averages while seeking mortgage licensing in more than 20 additional states. This push into AI-driven, lower-cost mortgages could make Opendoor’s platform more attractive to buyers by reducing financing friction and deepening its role in the transaction process. We’ll now explore how Opendoor’s AI-native, lower-rate mortgage...

VinFast Auto (NasdaqGS:VFS) has announced an alliance with NVIDIA and Autobrains to build a Level 4 autonomous driving platform tailored for Southeast Asia. The collaboration focuses on cost efficient, scalable self driving technology using NVIDIA's validated computing platform and Autobrains' specialized AI. The partners aim to address the complex driving conditions common across Southeast Asian roads and cities. For investors tracking VinFast Auto, the announcement comes with the stock at...

In late May 2026, Nano Nuclear Energy Inc. completed the acquisition of Secured Transportation Services and confirmed founder Roy A. Boyd II as President of the STS business, while the U.S. Nuclear Regulatory Commission accepted the construction permit application for the company’s KRONOS MMR at the University of Illinois Urbana-Champaign. Together, the STS deal and KRONOS MMR licensing progress show Nano Nuclear moving simultaneously on regulatory milestones and nuclear logistics...

Recent performance snapshot First Horizon (FHN) has drawn investor attention after a mixed performance in recent periods, with the stock down about 5.1% over the past month but slightly positive over the past 3 months. For context, the company reports revenue of US$3,429 million and net income of US$1,000 million. This gives investors a sense of current scale and profitability as they weigh the recent share price moves. See our latest analysis for First Horizon. While the share price has...

Super Micro Computer (NasdaqGS:SMCI) and Gorilla Technology have agreed a US$2b AI infrastructure supply deal for the Yotta project in India. The agreement covers tens of thousands of GPU cards and networking equipment to support Yotta's AI data centers. The companies also outlined a multi billion dollar framework to work together on AI infrastructure across India and the broader Asia Pacific region. For investors watching NasdaqGS:SMCI, this agreement highlights the company's role as a key...